The OTA may provide the market confidence that SYA will have a certain amount of spodumene concentrate to sell, hopefully with NAL ramped up to nameplate in 6 months as they say. Spot pricing doesn’t have the advantage that it used to in my view.
I suspect the large number of new short sales at low SP suggest that many are skeptical about SYA reaching nameplate
The OTA may provide the market confidence that SYA will have a...
-
- There are more pages in this discussion • 38,831 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SYA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $360.2M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.5¢ | 3.4¢ | $1.607M | 46.41M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 4668541 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 2167024 | 9 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| SYA (ASX) Chart |